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Brief Research ReportsPrime oxygen concentration has no effect on placental vascular
resistance for fetal cardiac bypass
Charles R. Cole, MD,a R. Scott Baker, BS,a Danielle Herbert, BS,a and Pirooz Eghtesady, MD, PhD,b
Cincinnati, Ohio, and St Louis, MoFIGURE 1. There is not a deleterious effect of prime PO2 concentration on
umbilical blood flow and umbilical vascular resistance at 2minutes after initi-
ation of bypass. There was no correlation between umbilical blood flow and
primePO2 (R
2¼0.115) (A)or betweenumbilical vascular resistanceandprime
PO2 (R
2 ¼ 0.175) (B). CPB, Cardiopulmonary bypass; Po2, oxygen tension.Our laboratory has been investigating fetal bypass for more
than a decade because of the possibility that fetal cardiac
interventions may prevent the development of certain
congenital heart lesions. In many of our studies and much
of the past experimental work, the placenta has served as
the sole source of oxygenation for fetal bypass because of
the long-standing prevailing hypothesis that high oxygen
tension (PO2) causes an increase in placental vascular resis-
tance.1,2 However, the effect of prime PO2 concentration on
placental vascular resistance and umbilical blood flow in
the setting of fetal bypass has not been reported in the
literature. Knowledge of the effect of prime PO2
concentration on placental vasculature is required to
determine whether unique circuitry is necessary for fetal
cardiac bypass. We have found that elevated PO2
concentration of the prime does not have an acute or
long-term deleterious effect on placental vascular resis-
tance, umbilical blood flow, or fetal metabolism. These
findings suggest that manipulation of the prime PO2 to
match fetal PO2 concentrations is not necessary and further
supports the potential efficacy of using modern clinical
tools used in neonatal practice with fetal bypass.
CLINICAL SUMMARY
All animals received humane care in compliance with the
Guide for the Care and Use of Laboratory Animals
(National Instititues of Health publication No. 85-23;
revised 1996). By using standard fetal bypass methods
that others and we have previously described,3,4 we
examined the effect of prime PO2 on the fetal blood lactate
and hemodynamic variables on 9 fetal sheep with a mean
gestational age of 116 days (term, 148 days). The
placenta served as the sole source of oxygen. The prime
PO2 was manipulated with nitrogen to create a range of
prime PO2 values, ranging from values corresponding to
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The Journal of Thoracic and Cartension, 20-120 mm Hg). Other prime values remained
consistent with previously described values.3 All animals
underwent 30 minutes of bypass with 90 minutes of
off-pump reperfusion. A 4- to 6-mm Doppler flow probe
(Transonic Systems, Ithaca, NY) placed on the common
umbilical artery measured umbilical blood flow. Placental
vascular resistance was calculated as reported previously.4
Fetal arterial, prime PO2, and lactate values were measured
with an i-STAT clinical analyzer (i-STATCorp,Windsor, NJ).
We examined the immediate effect of prime PO2 on
umbilical blood flow and umbilical vascular resistance at 2
minutes after initiation of bypass (Figure 1). There was no
correlation between umbilical blood flow (R2 ¼ 0.115) and
umbilical vascular resistance (R2 ¼ 0.175) according to
prime PO2 values. We next evaluated umbilical blood flow,
umbilical vascular resistance, and lactate values at the
conclusion of 30 minutes of bypass and again found no cor-
relation among umbilical blood flow (R2¼ 0.012), umbilical
vascular resistance (R2 ¼ 0.101), and serum lactatediovascular Surgery c Volume 147, Number 3 1107
FIGURE2. Therewas no correlation between prime PO2 concentration and umbilical blood flow, umbilical vascular resistance, or fetal lactate at 30minutes
after the initiation of cardiopulmonary or at 90 minutes post-bypass. CPB, Cardiopulmonary bypass; Po2, oxygen tension.
Brief Research Reports(R2¼ 0.129) related to prime oxygenvalues (Figure 2). Last,
we evaluated the long-term effect of prime oxygen on the
placental vasculature and fetal lactate at 90 minutes post-
bypass and found no correlation among umbilical blood
flow (R2 ¼ 0.089), umbilical vascular resistance
(R2¼ 0.122), and serum lactate (R2¼ 0.319) related to prime
PO2 values (Figure 2), but fetal lactatewas trending toward an
improved value for the animals that had a higher prime PO2.
DISCUSSION
Our findings indicated that elevated prime PO2 concentra-
tion does not have a deleterious effect on placental vascular
resistance, umbilical blood flow, or fetal metabolism.
Manipulating the prime oxygen to match fetal oxygen con-
centration as a therapeutic modality before fetal bypass
seems unnecessary, contrary to what was anticipated on
the basis of prior obstetrical studies.1,2 Furthermore our
data suggest that a moderate prime PO2 (50-80 mm Hg)
may be beneficial. Continued research has shown that
fetal bypass with ultra-filtration and the ability to modify
PO2, carbon dioxide, pH, and lactate levels can improve
fetal hemodynamic parameters during and after bypass.51108 The Journal of Thoracic and Cardiovascular SurA minimal circuit cannot ensure that the placenta and other
fetal organs receive oxygenated blood during bypass in
circumstances in which the placenta itself may be
compromised, such as fetal hydrops, which is a real
possibility in the clinical setting.
CONCLUSIONS
These findings suggest that experimental fetal bypass and
cardiac surgery may be feasible with standard clinical tools
currently used in neonatal practice.References
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